pik3ca_qpcr_-_website_packshot_-_720x440.png

APIS PIK3CA qPCR Kit (RUO*)

03102

The APIS PIK3CA Mutations Kit is a real-time qualitative PCR test for the detection of the five most prevalent activating mutations in the PIK3CA gene, using DNA extracted from either formalin-fixed, paraffin-embedded (FFPE) breast tumour tissue (gDNA) or blood plasma (cfDNA).
The kit includes mutation-specific probes to enable highly sensitive detection of the target mutations. Additionally, it uses PCR clamp and blocker technology, which ensures specific amplification of the mutant sequence, even in the presence of a high wild-type background.

Download Leaflet

Contact Us  Request Demo

*For Research Use Only (RUO), not for use in diagnostic procedures, developed by APIS and distributed by Biocartis NV. Data and conclusions have not been validated by Biocartis NV.

Benefits of Using APIS PIK3CA qPCR Kit

  • Detects 5 PIK3CA mutations, covering > 95% of actionable mutations
  • Highly sensitive detection at ≤ 0.5% mutant allele frequency (MAF)
  • Designed for FFPE tumour tissue (gDNA) or plasma (cfDNA)

APIS ESR1 and APIS PIK3CA qPCR Kits Bundle

The APIS PIK3CA qPCR Kit and APIS ESR1 qPCR Kit are available as a bundle for the detection of five PIK3CA mutations and eleven ESR1 mutations from DNA (both FFPE or cfDNA) using real-time qualitative PCR.

View APIS ESR1 qPCR Kit

apis_esr1_qpcr_kit_-_website_packshot_-_720x440.png

Discover the Breast Cancer Assay Portfolio

breast_women_nobg_cropped_smallerr.png